Ohio Republican David Taylor is not a household name. He doesn't have a Fox News hit lined up. He has no Google News coverage in the last 24 hours, zero stories, zero mentions, nothing. What he does have is 26 stock trades filed in the last 90 days, a portfolio that keeps flipping the same tickers, and a habit of buying on one day and selling on another that the disclosure system was specifically designed to make visible. Blind Trust noticed. The public record is interesting whether or not the press corps has caught up.
The Filings Are What They Are
Taylor sits on the House Committee on Agriculture and the House Committee on Transportation and Infrastructure. His committee remit covers commodity markets, highways, railroads, water resources, and rural credit. His portfolio, per Blind Trust's full disclosure record, covers Alphabet, Apple, AT&T, Home Depot, Parker Hannifin, Medpace Holdings, Procter & Gamble, Progressive, Visa, Broadcom, Lam Research, and Kroger. Spoiler: none of those are commodity exchanges or regional rail operators.
That's not a complaint. Members of Congress can hold what they hold. The system requires disclosure, not divestiture, and Taylor's filing record is right where it's supposed to be. But when a member who oversees agricultural credit and rural development is actively trading consumer staples, tech giants, and semiconductor names at a 26-trade clip across 90 days, the public record is allowed to ask what the thesis is.
The May 15 Cluster
Seven trades, one day.
On May 15, Taylor's disclosures show two separate sales of Alphabet (one in the 5K-$50K range, one in the K-5K range), a sale of Apple (K-5K), and purchases of Parker Hannifin, Medpace Holdings, Home Depot, and AT&T, all in the K-5K band. That's a rotation out of mega-cap tech and into industrials, a clinical-research name, a home-improvement retailer, and a telecom. The reasoning behind the rotation is not in any filing. Filings don't ask you to explain yourself.
AT&T is a specific note here. Taylor purchased AT&T in January 2026 as well, and that earlier buy returned 16.4% alpha over the following 30 days relative to the S&P 500, one of the three best single-trade performances in his scored history. Whether May's repurchase plays out the same way is not something any filing can tell you. The calendar just records when it happened.
The April 27 Cluster
Seven more trades, one day. April was apparently also a busy Monday.
On April 27, Taylor sold Home Depot, Broadcom, and Lam Research, all in the K-5K range, while simultaneously buying Home Depot, Procter & Gamble, Progressive, and Visa, also all K-5K. Selling and buying Home Depot on the same day is a specific kind of move. Whether it reflects a tax-lot strategy, a rebalancing, or something else entirely is not a question the filing system answers. The filing system just records the trade.
The Home Depot sale on April 27 produced the second-worst trade in Taylor's 90-day alpha record: negative 13.1% relative to the index over the following 30 days. Selling something that then went up is a rough outcome. It happens. Ninety-three scored trades is a real sample size, and Taylor's record across that full population is 51 wins against 42 losses, a coin flip with a slight edge, with a mean 30-day alpha of plus 1.3%. Not a trading prodigy. Not a disaster. Slightly better than the market, across a sample where nearly half the scored trades went the wrong way.
The Worst Trades Are Worth Naming
The Medpace Holdings sale from January 16 is the single worst trade in the scored record: negative 28.5% alpha over 30 days. Taylor sold Medpace in January. Medpace then ran. On May 15, he bought it back. The timing of the repurchase and the magnitude of the original loss are both just numbers in a public filing. The full record is here. Readers get to bring their own math.
Kroger, sold March 24 for K-5K, produced negative 13.3% alpha in the 30 days following. Two of the three worst trades in the record are sales, positions he exited before the underlying moved higher. Lam Research, also sold April 27, lands in the top three of worst trades in the recent cluster. But Lam Research was also Taylor's single best trade earlier in the sample: a purchase on March 12 that returned 21.2% alpha over 30 days. He bought it well. He then sold it at a loss. Both of those things are in the same portfolio.
What the Votes Look Like
On May 20 and 21, Taylor voted yes on a slate of bills: the American Access to Banking Act, the Community Bank Deposit Access Act of 2025, the Keeping Deposits Local Act, a 9/11 commemorative coin bill, Lulu's Law, and two veterans benefits bills. He voted yes on all of them. Every vote passed.
The banking bills are the most market-relevant votes in the recent record, rated 95 out of 100 for market relevance by Blind Trust's scoring system. Taylor's committees don't include Financial Services. He's on Agriculture and Transportation. A floor vote on a banking access bill is a floor vote, not a committee action, he has no particular oversight remit here, and there's no flagged trade-vote overlap in the data. The votes are votes. The trades are trades. The overlap table for Taylor is empty.
Worth noting anyway: Visa, which Taylor bought on April 27, operates in the payments infrastructure that community banking legislation directly touches. Progressive Insurance sits in a regulatory environment adjacent to financial services reform. Whether that connection is meaningful or coincidental is a judgment call the filing system doesn't make for you.
The Volume Itself Is the Story
Twenty-six disclosed trades in 90 days works out to roughly two trades a week on average. Most of those are in the K-5K range, not enormous sums, but the frequency is the thing. Congressional trading is often defended on the grounds that the amounts are small. The STOCK Act's disclosure requirement was built around the idea that frequency and timing matter even when individual amounts don't. Taylor is using that system as designed, filing every trade, meeting every deadline.
Members are required to disclose. They are not required to divest, recuse, abstain, blush, or look up from their phones.
The social record shows the disclosures are getting noticed: Bluesky posts flagging the April 27 batch and the May 15 batch have circulated in the transparency-tracking community over the last few weeks. Not viral. Not trending. But the people who watch these filings are watching these filings.
The Committee Angle That Is not There
Worth being direct about this: none of Taylor's disclosed trades in the last 90 days carry a committee-overlap flag. His Agriculture committee work covers commodity markets, rural credit, and risk management. His Transportation committee work covers highways, railroads, pipelines, and water resources. Broadcom makes semiconductors. Alphabet makes search engines. Medpace runs clinical trials. Lam Research makes chip-manufacturing equipment. Kroger sells groceries, which is at least adjacent to agriculture, but in the same way that a painting of a barn is adjacent to farming.
There's no flagged conflict in the record. The record is just active.
The Scorecard
The math across 93 scored trades: 51 positive alpha outcomes, 42 negative. Mean 30-day excess return versus the S&P 500: plus 1.3%. The best single trade in the record is the March 2026 Lam Research purchase at plus 21.2%. The worst is the January 2026 Medpace sale at negative 28.5%. Taylor then bought Medpace back four months later.
A 1.3% It's also not evidence of anything improper. It's a modestly positive return over a large enough sample that the signal is real but small. Fifty-one wins and 42 losses across that sample is a record any retail investor would recognize: more right than wrong, but not by enough to brag about at the constituent town hall.
The receipts are public. Make of them what you make of them.